Zevra Therapeutics, Inc.

NasdaqGS:ZVRA Stock Report

Market Cap: US$189.2m

Zevra Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:ZVRA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Sep 23BuyUS$48,764Thomas AndersonIndividual10,000US$4.88
06 Sep 23BuyUS$4,959R. CliftonIndividual1,000US$4.96
05 Sep 23BuyUS$51,333John BodeIndividual10,000US$5.13
05 Sep 23BuyUS$2,565Joshua SchaferIndividual500US$5.13
23 Jun 23BuyUS$1,636Corey WattonIndividual275US$5.95
09 Jun 23BuyUS$1,794Corey WattonIndividual325US$5.52
30 May 23BuyUS$2,042Corey WattonIndividual400US$5.11
19 May 23BuyUS$5,416Joshua SchaferIndividual1,000US$5.42
18 May 23BuyUS$50,418John BodeIndividual10,000US$5.05
18 May 23BuyUS$13,562R. CliftonIndividual2,740US$4.95

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ZVRA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies30,5310.073%
Hedge Funds2,453,4055.86%
Individual Insiders3,279,6867.84%
Institutions10,423,00724.9%
General Public25,663,86561.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.2%.


Top Shareholders

Top 25 shareholders own 35.94% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.22%
Samuel Braun
3,021,660US$13.7m0%no data
5.86%
Nantahala Capital Management, LLC
2,453,405US$11.1m6.29%1.1%
5.76%
BlackRock, Inc.
2,410,289US$10.9m12.1%no data
3.93%
The Vanguard Group, Inc.
1,645,140US$7.4m2.02%no data
1.74%
Geode Capital Management, LLC
729,179US$3.3m7.38%no data
1.63%
Janney Montgomery Scott LLC, Asset Management Arm
683,431US$3.1m1.34%0.01%
1.52%
State Street Global Advisors, Inc.
636,060US$2.9m1.25%no data
1.29%
683 Capital Management, LLC
540,800US$2.4m0%0.22%
0.93%
The Retirement Planning Company of New England, Inc.
387,427US$1.8m11.5%0.74%
0.8%
Citadel Advisors LLC
334,777US$1.5m99.7%no data
0.72%
Northern Trust Global Investments
301,066US$1.4m11.3%no data
0.64%
Armistice Capital LLC
268,000US$1.2m0%0.03%
0.55%
Mystic Asset Management, Inc.
230,783US$1.0m13.5%0.47%
0.48%
BNY Mellon Asset Management
199,268US$900.7k-1.73%no data
0.41%
Renaissance Technologies LLC
170,500US$770.7k28.5%no data
0.34%
Travis Mickle
142,548US$644.3k0%no data
0.34%
Kovack Advisors, Inc., Asset Management Arm
141,846US$641.2k0.31%0.08%
0.31%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
129,730US$586.4k0%no data
0.27%
Susquehanna International Group, LLP, Asset Management Arm
114,862US$519.2k159%no data
0.23%
Charles Schwab Investment Management, Inc.
96,130US$434.5k0%no data
0.23%
Bridgeway Capital Management, LLC
95,143US$430.0k0%0.01%
0.21%
DIMlux S.A.
89,000US$402.3k0%0.54%
0.19%
Arete Wealth Advisors, LLC
80,433US$363.6k-0.37%0.03%
0.17%
Stratos Wealth Partners, Ltd
70,240US$317.5k0%0.01%
0.17%
Morgan Stanley, Investment Banking and Brokerage Investments
69,622US$314.7k250%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.